Evofem Biosciences Successfully Extends Cumulative Net Sales Covenant Timing to June 30, 2023
- Monday, November 22, 2021, 7:07
- Finance
- Add a comment
SAN DIEGO, Nov. 22, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that it has successfully extended the cumulative net sales covenant timing of its April 2020 Securities Purchase and Security Agreement to June 30, 2023. “We appreciate that these healthcare…
About the Author
adminasapcorp has written 41552 stories on this site.